Heart drug showdown: which works best after bypass?
NCT ID NCT07144267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs, milrinone and epinephrine, to treat right heart dysfunction that can occur after cardiac surgery. The trial will enroll 102 adults undergoing heart surgery with a heart-lung machine. The goal is to see which drug better improves right heart function right after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- milrinone and epinephrine
- What this could lead to
- If this trial succeeds, it could show which drug is better at helping the right side of the heart recover after heart surgery, potentially improving patient outcomes.
- What could go wrong
- This is a small, early-stage trial with only 102 participants, so results may not apply to everyone. Both drugs have known side effects like arrhythmias.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ANAESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Calcium timing during bypass may cut need for heart drugs
- Double nerve block may ease pain and speed recovery after heart surgery
- New dashboard aims to give surgeons a complete view during heart surgery
- Could a simple nerve block transform heart surgery recovery?
- Old sedative, new trick: amobarbital may shield the heart during bypass surgery
- Could a softer Heart-Lung machine protect the brain during surgery?